Found 19 matching trials
Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients PHASE2 5 month study comparing SOM230 s.c. and Sandostatin s.c. in acromegalic pat...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial
A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease PHASE2 The study treatment period is 15 days in length and includes patients with ...
Show More Location
Cedars-Sinai Pituitary Center
Learn More & Join Trial
IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus PHASE2 Observe the safety/tolerability and effectiveness in terms of response rate...
Show More Location
Penn State Milton S. Hershey Medical Center
Learn More & Join Trial
An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. PHASE3 This study provided access to pasireotide sc in patients with Cushing's dis...
Show More Location
Advanced Research, LLC
Learn More & Join Trial
Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease PHASE3 The purpose of this randomized, multicenter, Phase III study was to compare...
Show More Location
Scottsdale Healthcare/TGen Clinical Research Service TGen Clinical Research Service
Learn More & Join Trial
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas PHASE2 There are no available medical treatment options for patients with non-func...
Show More Location
Endocrinology Section - Hospital Universitário Clementino Fraga Filho/Federal University of Rio de Janeiro
Learn More & Join Trial
Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease N/A This is a non-interventional, multinational, multi-center post-marketing st...
Show More Location
St Josephs Hospital and Medical Center
Learn More & Join Trial
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors PHASE1 The purpose of this research study is to determine the safety of the combin...
Show More Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial
Pasireotide in Hyperinsulinemic Hypoglycemia PHASE2 This is a small controlled pilot study to assess the effect of subcutaneous...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers PHASE1 The purpose of this study is to assess the effect of renal impairment on th...
Show More Location
Novartis Investigative Site
Learn More & Join Trial